Marianne Farnebo

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: MOLECULAR ONCOLOGY. 2023;17(10):2029-2040

Low levels of WRAP53 predict decreased efficacy of radiotherapy and are prognostic for local recurrence and death from breast cancer: a long-term follow-up of the SweBCG91RT randomized trial.

Egelberg M; De Marchi T; Pekar G; Tran L; Bendahl P-O; Tullberg AS; Holmberg E; Karlsson P; Farnebo M; Killander F; Nimeús E
Article: NATURE COMMUNICATIONS. 2022;13(1):1015

Small Cajal body-associated RNA 2 (scaRNA2) regulates DNA repair pathway choice by inhibiting DNA-PK.

Bergstrand S; O'Brien EM; Coucoravas C; Hrossova D; Peirasmaki D; Schmidli S; Dhanjal S; Pederiva C; Siggens L; Mortusewicz O; O'Rourke JJ; Farnebo M
Article: ONCOLOGY LETTERS. 2022;23(1):30

Evaluation of dyskerin expression and the Cajal body protein WRAP53β as potential prognostic markers for patients with primary vaginal carcinoma.

Ranhem C; Larsson GL; Lindqvist D; Sorbe B; Karlsson MG; Farnebo M; Hellman K; Kovaleska L; Kashuba E; Andersson S
Article: CELL DEATH & DISEASE. 2020;11(4):238

Biallelic mutations in WRAP53 result in dysfunctional telomeres, Cajal bodies and DNA repair, thereby causing Hoyeraal-Hreidarsson syndrome.

Bergstrand S; Böhm S; Malmgren H; Norberg A; Sundin M; Nordgren A; Farnebo M
Article: CELL CHEMICAL BIOLOGY. 2019;26(10):1436-1449.e5

Neutralization of the Positive Charges on Histone Tails by RNA Promotes an Open Chromatin Structure.

Dueva R; Akopyan K; Pederiva C; Trevisan D; Dhanjal S; Lindqvist A; Farnebo M
Article: ONCOLOGY REPORTS. 2017;38(4):2062-2068

WRAP53β, survivin and p16INK4a expression as potential predictors of radiotherapy/chemoradiotherapy response in T2N0-T3N0 glottic laryngeal cancer.

Tiefenböck-Hansson K; Haapaniemi A; Farnebo L; Palmgren B; Tarkkanen J; Farnebo M; Munck-Wikland E; Mäkitie A; Garvin S; Roberg K
Article: RNA BIOLOGY. 2017;14(6):804-813

Phosphorylation of the Cajal body protein WRAP53β by ATM promotes its involvement in the DNA damage response.

Coucoravas C; Dhanjal S; Henriksson S; Böhm S; Farnebo M
Article: CELL DEATH AND DIFFERENTIATION. 2016;23(10):1648-1657

Splicing controls the ubiquitin response during DNA double-strand break repair.

Pederiva C; Böhm S; Julner A; Farnebo M
Article: CELL DEATH & DISEASE. 2016;7(6):e2267

Overexpression of the scaffold WD40 protein WRAP53β enhances the repair of and cell survival from DNA double-strand breaks.

Rassoolzadeh H; Böhm S; Hedström E; Gad H; Helleday T; Henriksson S; Farnebo M
Article: CELL DEATH & DISEASE. 2015;6(10):e1892

Downregulation of the cancer susceptibility protein WRAP53β in epithelial ovarian cancer leads to defective DNA repair and poor clinical outcome.

Hedström E; Pederiva C; Farnebo J; Nodin B; Jirström K; Brennan DJ; Farnebo M
Article: NUCLEUS. 2015;6(5):417-424

The proximity ligation assay reveals that at DNA double-strand breaks WRAP53β associates with γH2AX and controls interactions between RNF8 and MDC1.

Rassoolzadeh H; Coucoravas C; Farnebo M
Article: ORAL ONCOLOGY. 2015;51(1):24-30

Nuclear expression of WRAP53β is associated with a positive response to radiotherapy and improved overall survival in patients with head and neck squamous cell carcinoma.

Garvin S; Tiefenböck K; Farnebo L; Thunell LK; Farnebo M; Roberg K
Article: PLOS ONE. 2015;10(10):e0139965

The Sub-Cellular Localization of WRAP53 Has Prognostic Impact in Breast Cancer.

Silwal-Pandit L; Russnes H; Borgen E; Skarpeteig V; Moen Vollan HK; Schlichting E; Kåresen R; Naume B; Børresen-Dale A-L; Farnebo M; Langerød A
Article: GENES & DEVELOPMENT. 2014;28(24):2726-2738

The scaffold protein WRAP53β orchestrates the ubiquitin response critical for DNA double-strand break repair.

Henriksson S; Rassoolzadeh H; Hedström E; Coucoravas C; Julner A; Goldstein M; Imreh G; Zhivotovsky B; Kastan MB; Helleday T; Farnebo M
Article: CELL DEATH & DISEASE. 2011;2(1):e114

WRAP53 promotes cancer cell survival and is a potential target for cancer therapy.

Mahmoudi S; Henriksson S; Farnebo L; Roberg K; Farnebo M
Article: PLOS BIOLOGY. 2010;8(11):e1000521

WRAP53 is essential for Cajal body formation and for targeting the survival of motor neuron complex to Cajal bodies.

Mahmoudi S; Henriksson S; Weibrecht I; Smith S; Söderberg O; Strömblad S; Wiman KG; Farnebo M
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2010;37(1):15-20

Sorafenib induces apoptosis and autophagy in prostate cancer cells in vitro.

Ullén A; Farnebo M; Thyrell L; Mahmoudi S; Kharaziha P; Lennartsson L; Grandér D; Panaretakis T; Nilsson S
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2010;396(1):85-89

The p53 tumor suppressor: a master regulator of diverse cellular processes and therapeutic target in cancer.

Farnebo M; Bykov VJN; Wiman KG
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2009;106(37):15756-15761

The p53 target Wig-1 regulates p53 mRNA stability through an AU-rich element.

Vilborg A; Glahder JA; Wilhelm MT; Bersani C; Corcoran M; Mahmoudi S; Rosenstierne M; Grandér D; Farnebo M; Norrild B; Wiman KG
Article: CELL CYCLE. 2009;8(15):2343-2346

Wrap53, a novel regulator of p53.

Farnebo M
Article: MOLECULAR CELL. 2009;33(4):462-471

Wrap53, a natural p53 antisense transcript required for p53 induction upon DNA damage.

Mahmoudi S; Henriksson S; Corcoran M; Méndez-Vidal C; Wiman KG; Farnebo M
Article: EXPERIMENTAL CELL RESEARCH. 2007;313(19):4015-4024

Interferon alpha induces cell death through interference with interleukin 6 signaling and inhibition of STAT3 activity.

Thyrell L; Arulampalam V; Hjortsberg L; Farnebo M; Grandér D; Pokrovskaja Tamm K
Article: HUMAN MOLECULAR GENETICS. 2004;13(23):2925-2936

Disruption of a novel ectodermal neural cortex 1 antisense gene, ENC-1AS and identification of ENC-1 overexpression in hairy cell leukemia.

Hammarsund M; Lerner M; Zhu C; Merup M; Jansson M; Gahrton G; Kluin-Nelemans H; Einhorn S; Grandér D; Sangfelt O; Corcoran M
Article: GENES CHROMOSOMES & CANCER. 2004;40(4):285-297

DLEU2 encodes an antisense RNA for the putative bicistronic RFP2/LEU5 gene in humans and mouse.

Corcoran MM; Hammarsund M; Zhu C; Lerner M; Kapanadze B; Wilson B; Larsson C; Forsberg L; Ibbotson RE; Einhorn S; Oscier DG; Grandér D; Sangfelt O
Article: FEBS LETTERS. 2004;556(1-3):75-80

Characterization of a novel B-CLL candidate gene--DLEU7--located in the 13q14 tumor suppressor locus.

Hammarsund M; Corcoran MM; Wilson W; Zhu C; Einhorn S; Sangfelt O; Grandér D
Article: GENE. 2003;321:103-112

Distinct organization of the candidate tumor suppressor gene RFP2 in human and mouse: multiple mRNA isoforms in both species- and human-specific antisense transcript RFP2OS.

Baranova A; Hammarsund M; Ivanov D; Skoblov M; Sangfelt O; Corcoran M; Borodina T; Makeeva N; Pestova A; Tyazhelova T; Nazarenko S; Gorreta F; Alsheddi T; Schlauch K; Nikitin E; Kapanadze B; Shagin D; Poltaraus A; Ivanovich Vorobiev A; Zabarovsky E; Lukianov S; Chandhoke V; Ibbotson R; Oscier D; Einhorn S; Grander D; Yankovsky N
Article: HUMAN GENETICS. 2001;109(5):542-550

Identification and characterization of two novel human mitochondrial elongation factor genes, hEFG2 and hEFG1, phylogenetically conserved through evolution.

Hammarsund M; Wilson W; Corcoran M; Merup M; Einhorn S; Grandér D; Sangfelt O
Article: GENOMICS. 2000;70(3):327-334

Comparative sequence analysis of a region on human chromosome 13q14, frequently deleted in B-cell chronic lymphocytic leukemia, and its homologous region on mouse chromosome 14.

Kapanadze B; Makeeva N; Corcoran M; Jareborg N; Hammarsund M; Baranova A; Zabarovsky E; Vorontsova O; Merup M; Gahrton G; Jansson M; Yankovsky N; Einhorn S; Oscier D; Grandér D; Sangfelt O
Visa fler

Alla övriga publikationer

Editorial comment: NATURE REVIEWS MOLECULAR CELL BIOLOGY. 2020;21(2):65

Rise of the neglected repeats RNA.

Farnebo M
Review: FRONTIERS IN MOLECULAR BIOSCIENCES. 2019;6:51

The Cajal Body Protein WRAP53β Prepares the Scene for Repair of DNA Double-Strand Breaks by Regulating Local Ubiquitination.

Bergstrand S; O'Brien EM; Farnebo M
Editorial comment: CELL CYCLE. 2018;17(2):137-138

RNF8 - The Achilles heel of DNA repair when splicing rules.

Pederiva C; Farnebo M
Review: FRONTIERS IN GENETICS. 2015;6:91

On the road with WRAP53β: guardian of Cajal bodies and genome integrity.

Henriksson S; Farnebo M
Letter: NATURE METHODS. 2011;8(11):892-893

Increasing the dynamic range of in situ PLA.

Clausson C-M; Allalou A; Weibrecht I; Mahmoudi S; Farnebo M; Landegren U; Wählby C; Söderberg O

Anställningar

Lektor, Onkologi-Patologi, Karolinska Institutet, 2024-
Forskare, Cell- och molekylärbiologi, Karolinska Institutet, 2018-2023

Examina och utbildning

Docent, Experimentell onkologi, Karolinska Institutet, 2011
MEDICINE DOKTORSEXAMEN, Institutionen för onkologi-patologi, Karolinska Institutet, 2003
Medicine Magisterexamen, Karolinska Institutet, 1999

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI